Description colorless, clear liquid
Indications
Tulathromycin Injectable Solution is indicated for the treatment of swine
respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica and Haemophilus parasuis.
Pharmacological Actions
Tulathromycin, the active ingredient of Tulathromycin Injectable Solution, is a novel antimicrobial from the triamilide class, developed by Pfizer scientists specifically for swine respiratory disease. Tulathromycin provides excellent clinical efficacy against key bacterial pathogens that cause complex swine respiratory disease.
Dosage and Administration
The recommended dose is single dose of 2.5 mg/kg (1 mL/88lb) administrated Intramuscularly in the neck of swine. The total dosage of per injection site should not exceed 2.5mL.
Precautions
Intramuscular injection can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.
In one field study, 1 out of 40 pigs treated with Tulathromycin at 2.5 mg/kg BW exhibited mild salivation that resolved in less than 4 hours. The use of Tulathromycin Injectable Solution is contraindicated in animals previously found to be hypersensitive to the drug.
Storage Store at or below 25°C
Withdrawal period 5 days for swine
Shelf life 2 years